Crucell and NatImmune Sign Licensing Agreement
By Business Review Editor
Pharma Deals Review: Vol 2002 Issue 28 (Table of Contents)
Published: 2 Sep-2002
DOI: 10.3833/pdr.v2002.i28.1005 ISSN: 1756-7874
Section: Licensing
Fulltext:
Abstract
Crucell signed a research licensing agreement with NatImmune to evaluate the production of the therapeutic protein, mannan-binding lectin (MBL) on PER...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018